Back Policy/Litigation
Back Resolutions
Back Current Initiatives
Back Donate
Home » In The News » Big Pharma: investors want to act on drug prices

Big Pharma: investors want to act on drug prices

American pharmaceutical companies are facing a wave of protest from investors. AbbVie, Eli Lilly, Gilead, Johnson & Johnson, Merck and Pfizer are targeted by a shareholder engagement campaign to improve access to medicines and reduce costs. A common practice of laboratories is particularly targeted, that of the extension of the duration of patents which allows a company to keep the marketing of a drug for itself, and therefore to set the price, for which two resolutions have been filed. at the general meetings of AbbVie and Eli Lilly.

Read the full article in DayFR Euro